Alport Syndrome clinical trials at University of California Health

1 in progress, 0 open to eligible people

Vonafexor ALPort Syndrome Efficacy & Safety TRIAl-1 (ALPESTRIA-1)
Sorry, in progress, not accepting new patients
This study is a proof-of-concept trial of vonafexor safety, its effects on kidney function in subjects with at risk of progression Alport syndrome.
at UCLA

Our lead scientists for Alport Syndrome research studies include Anjay Rastogi, MD, PhD.

Last updated: March 31, 2025